Aptevo Therapeutics Q1 EPS $(9.95) Beats $(12.84) Estimate
Aptevo Therapeutics Q1 EPS $(9.95) Beats $(12.84) Estimate
Aptevo Therapeutics第一季度每股收益美元(9.95美元)超過預期(12.84美元)
Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(9.95) per share which beat the analyst consensus estimate of $(12.84) by 22.51 percent. This is a 76.92 percent increase over losses of $(43.12) per share from the same period last year.
Aptevo Therapeutics(納斯達克股票代碼:APVO)公佈的季度虧損爲每股9.95美元(9.95美元),比分析師普遍預期的12.84美元(12.84美元)高出22.51%。這比去年同期每股虧損43.12美元(43.12美元)增長了76.92%。